Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

American Heart Journal

Volumn 160, Issue 6, 2010, Pages

  Mauri, Laura ^a,b   Kereiakes, Dean J ^c   Normand, Sharon Lise T ^b,d   Wiviott, Stephen D ^a,b   Cohen, David J ^e   Holmes, David R ^f   Bangalore, Sripal ^a,b   Cutlip, Donald E ^b,g   Pencina, Michael ^h   Massaro, Joseph M ^h  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c The Carl & Edyth Lindner Center for Research & Education   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^f ST MARY S HOSPITAL   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO; PRASUGREL;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; STENT THROMBOSIS; TREATMENT DURATION;

EID: 78650097647     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.07.038     Document Type: Article

References (24)

1. Moses J.W., Leon M.B., and Popma J.J. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
2. Stone G.W., Ellis S.G., and Cox D.A. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
3. Pfisterer M., Brunner-La Rocca H.P., and Buser P.T. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
4. Mauri L., Hsieh W.h., and Massaro J.M. Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
5. Daemen J., Wenaweser P., and Tsuchida K. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
6. Stettler C., Wandel S., and Allemann S. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
7. Budaj A., Yusuf S., and Mehta S.R. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups Circulation 106 2002 1622 1626
8. Grines C.L., Bonow R.O., and Casey D.E. Jr. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians J Am Coll Cardiol 49 2007 734 739
9. Mehta S.R., Yusuf S., and Peters R.J. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
10. Steinhubl S.R., Berger P.B., and Mann J.T. III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
11. Wiviott S.D., Braunwald E., and McCabe C.H. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
12. Wiviott S.D., Braunwald E., and McCabe C.H. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
13. Yusuf S., Zhao F., and Mehta S.R. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
14. Eisenstein E.L., Anstrom K.J., and Kong D.F. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation JAMA 297 2007 159 168
15. Park S.J., Park D.W., and Kim Y.H. Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
16. Cutlip D.E., Chhabra A.G., and Baim D.S. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials Circulation 110 2004 1226 1230
17. Bhatt D.L., Fox K.A., and Hacke W. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
18. Campbell C.L., Smyth S., and Montalescot G. Aspirin dose for the prevention of cardiovascular disease: a systematic review JAMA 297 2007 2018 2024 (Pubitemid 46740354)
19. Cutlip D.E., Windecker S., and Mehran R. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
20. GUSTO An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
21. Hotchberg Y. A sharper bonferroni procedure for multiple significance testing Biometrika 75 1988 800 803
22. Stone G.W., Moses J.W., and Ellis S.G. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
23. Bhatt D.L., Flather M.D., and Hacke W. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA Trial J Am College of Cardiol 49 2007 1982 1988
24. Lakatos E. Sample sizes based on the log-rank statistic in complex clinical trials Biometrics 44 1988 229 241